fingolimod hydrochloride has been researched along with Acute Lung Injury in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bandela, M; Belvitch, P; Brown, ME; Chen, J; Dudek, SM; Garcia, JGN; Letsiou, E; Meliton, LN; Wang, H; Wang, L | 1 |
| An, S; Gao, C; Huang, J; Jiang, R; Luo, H; Qian, Y; Song, Y; Zhang, J; Zhao, X | 1 |
| Chen, CL; Shi, ZA; Tu, FP; Wan, Y; Wu, ZC; Yu, CX | 1 |
| Kang, DL; Li, TT; Shi, ZA; Su, H; Tu, FP | 1 |
| Bai, C; Chen, H; Huang, Z; Liu, G; Liu, H; Niu, W; Qin, Y; Wen, G; Zhang, X; Zhao, Y; Zhu, C | 1 |
| Bai, C; Chen, H; Huang, Z; Liu, G; Liu, H; Niu, W; Qin, Y; Wang, H; Wang, S; Zhang, X | 1 |
| Abassi, T; Berdyshev, E; Bittman, R; Dudek, SM; Garcia, JG; Huang, LS; Jacobson, JR; Mathew, B; Moreno-Vinasco, L; Natarajan, V; Wang, L; Weichselbaum, R; Zhao, Y | 1 |
| Bittman, R; Camp, SM; Dudek, SM; Garcia, JG; Letsiou, E; Moreno-Vinasco, L; Sammani, S; Wang, L; Wang, T | 1 |
| Lv, L; Qian, J; Ye, S; Ye, Y; Zhu, C | 1 |
| Bonitz, JA; Chandler, B; Deitch, EA; Feketeova, E; Prescott, LM; Qin, Y; Son, JY; Tomaio, JN | 1 |
| Hla, T; Proia, RL | 1 |
| Bittman, R; Dudek, SM; Garcia, JG; Wang, L | 1 |
2 review(s) available for fingolimod hydrochloride and Acute Lung Injury
| Article | Year |
|---|---|
Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Biomarkers; Capillary Permeability; Fingolimod Hydrochloride; Humans; Lung; Lysophospholipids; Membrane Proteins; Nerve Tissue Proteins; Phosphotransferases (Alcohol Group Acceptor); Pneumonia; Propylene Glycols; Receptors, Lysosphingolipid; Sepsis; Sphingosine; Transferases (Other Substituted Phosphate Groups); Translational Research, Biomedical | 2013 |
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.
Topics: Acute Lung Injury; Anemia, Sickle Cell; Animals; Autoimmune Diseases; Cardiovascular Diseases; Cell Physiological Phenomena; Disease Models, Animal; Fingolimod Hydrochloride; Hematopoietic Stem Cell Mobilization; Humans; Influenza, Human; Lysophospholipids; Membrane Lipids; Mice; Multiple Sclerosis; Neoplasms; Neovascularization, Physiologic; Neurogenesis; Propylene Glycols; Receptors, Lysosphingolipid; Sphingolipids; Sphingosine | 2015 |
10 other study(ies) available for fingolimod hydrochloride and Acute Lung Injury
| Article | Year |
|---|---|
MRSA-induced endothelial permeability and acute lung injury are attenuated by FTY720 S-phosphonate.
Topics: Acute Lung Injury; Animals; Antigens, CD; Cadherins; Cell Membrane Permeability; Cytoprotection; Cytoskeleton; Endothelial Cells; Enzyme Activation; Fingolimod Hydrochloride; Humans; Inflammation; Methicillin-Resistant Staphylococcus aureus; Mice; Myosin Light Chains; Organophosphonates; Phosphorylation; rhoA GTP-Binding Protein; Signal Transduction | 2022 |
Fingolimod Attenuates Lung Injury and Cardiac Dysfunction after Traumatic Brain Injury.
Topics: Acute Lung Injury; Animals; Brain Injuries, Traumatic; Cardiac Output; Cytokines; Disease Models, Animal; Echocardiography; Fingolimod Hydrochloride; Heart Diseases; Lung; Male; Mice; Mice, Inbred C57BL; Myocardium; Sphingosine 1 Phosphate Receptor Modulators | 2020 |
The effect of FTY720 at different doses and time-points on LPS-induced acute lung injury in rats.
Topics: Acute Lung Injury; Animals; Blood Gas Analysis; Blood-Air Barrier; Cytokines; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Immunosuppressive Agents; Injections, Intraperitoneal; Lipopolysaccharides; Lung; Male; NF-kappa B; Oxygen; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed | 2021 |
Fingolimod attenuates renal ischemia/reperfusion-induced acute lung injury by inhibiting inflammation and apoptosis and modulating S1P metabolism.
Topics: Acute Lung Injury; Animals; Apoptosis; Fingolimod Hydrochloride; Inflammation; Ischemia; Lysophospholipids; Rats; Reperfusion; Reperfusion Injury; Sphingosine | 2021 |
Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models.
Topics: Acute Lung Injury; Animals; Combined Modality Therapy; Female; Fingolimod Hydrochloride; Gene Expression Profiling; Immunosuppressive Agents; Lipopolysaccharides; Lung; Mesenchymal Stem Cell Transplantation; Mice, Inbred C57BL; Respiratory Distress Syndrome | 2018 |
LncRNA analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models.
Topics: Acute Lung Injury; Animals; Combined Modality Therapy; Disease Models, Animal; Fingolimod Hydrochloride; Gene Expression Regulation; Gene Ontology; Humans; Immunosuppressive Agents; Lipopolysaccharides; Lung; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Pneumonia; RNA, Long Noncoding; Signal Transduction; Umbilical Cord | 2019 |
FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
Topics: Acute Lung Injury; Animals; Arrestins; beta-Arrestins; Bleomycin; Blotting, Western; Capillary Permeability; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Fingolimod Hydrochloride; Fluorescent Antibody Technique; Humans; Mice; Mice, Inbred C57BL; Propylene Glycols; Random Allocation; Receptors, G-Protein-Coupled; Receptors, Lysosphingolipid; Sensitivity and Specificity; Sphingosine | 2014 |
FTY720 attenuates paraquat-induced lung injury in mice.
Topics: Actins; Acute Lung Injury; Animals; Body Weight; Bronchoalveolar Lavage Fluid; Collagen Type I; Collagen Type III; Disease Models, Animal; Fingolimod Hydrochloride; Interleukin-1beta; Interleukin-6; Lung; Lung Injury; Mice; Mice, Inbred C57BL; Paraquat; Propylene Glycols; Pulmonary Edema; Pulmonary Fibrosis; Sphingosine; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2014 |
A sphingosine-1 phosphate agonist (FTY720) limits trauma/hemorrhagic shock-induced multiple organ dysfunction syndrome.
Topics: Acute Lung Injury; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocyte Deformability; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Multiple Organ Failure; Neutrophil Activation; Propylene Glycols; Rats, Sprague-Dawley; Respiratory Burst; Shock, Hemorrhagic; Sphingosine | 2014 |
Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonate.
Topics: Acute Lung Injury; Antigens, CD; Antigens, Nuclear; Cadherins; Endothelial Cells; Fingolimod Hydrochloride; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Humans; Immunosuppressive Agents; Lung; Lysophospholipids; Microscopy, Fluorescence; Nerve Tissue Proteins; Organophosphonates; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Receptors, Lysosphingolipid; RNA, Small Interfering; Sphingosine; Transcription Factors; Zonula Occludens-1 Protein | 2015 |